- Review
- Korean J Med. 2008;75(1):312-312.
- Phase 2 study of Low dose Leucovorin- modified FOLFIRI as first line therapy for patients with recurrent or metastatic gastric cancer (초)
- Byung Geun Kim, Sung Yong Oh, Suee Lee, Dong Mee Lee, Jung Hwan Kim, Sung Hyun Kim, Hyuk Chan Kwon, Hyo Jin Kim
- Byung Geun Kim, Sung Yong Oh, Suee Lee, Dong Mee Lee, Jung Hwan Kim, Sung Hyun Kim, Hyuk Chan Kwon, Hyo Jin Kim
 |
 |
 |
 |
 |
 |